Elo Mutual Pension Insurance Co Grows Position in Agilent Technologies, Inc. (NYSE:A)

Elo Mutual Pension Insurance Co increased its position in shares of Agilent Technologies, Inc. (NYSE:AFree Report) by 3.4% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 25,544 shares of the medical research company’s stock after buying an additional 851 shares during the quarter. Elo Mutual Pension Insurance Co’s holdings in Agilent Technologies were worth $3,551,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Empirical Financial Services LLC d.b.a. Empirical Wealth Management lifted its position in Agilent Technologies by 3.2% during the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 2,421 shares of the medical research company’s stock worth $337,000 after acquiring an additional 75 shares during the period. Carmel Capital Partners LLC lifted its position in Agilent Technologies by 1.2% during the 4th quarter. Carmel Capital Partners LLC now owns 6,709 shares of the medical research company’s stock worth $933,000 after acquiring an additional 78 shares during the period. Monumental Financial Group Inc. lifted its position in Agilent Technologies by 0.9% during the 4th quarter. Monumental Financial Group Inc. now owns 9,493 shares of the medical research company’s stock worth $1,320,000 after acquiring an additional 89 shares during the period. Kepos Capital LP lifted its holdings in shares of Agilent Technologies by 3.5% in the 3rd quarter. Kepos Capital LP now owns 2,775 shares of the medical research company’s stock valued at $310,000 after buying an additional 93 shares during the period. Finally, Rosenberg Matthew Hamilton lifted its holdings in shares of Agilent Technologies by 51.1% in the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock valued at $39,000 after buying an additional 96 shares during the period.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $133.07 on Tuesday. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The stock has a market capitalization of $38.82 billion, a P/E ratio of 31.46, a PEG ratio of 4.51 and a beta of 1.07. The company has a current ratio of 2.15, a quick ratio of 1.64 and a debt-to-equity ratio of 0.34. The business’s fifty day moving average price is $141.86 and its 200 day moving average price is $138.06.

Agilent Technologies (NYSE:AGet Free Report) last issued its earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, beating analysts’ consensus estimates of $1.19 by $0.03. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The firm had revenue of $1.57 billion for the quarter, compared to analysts’ expectations of $1.58 billion. During the same quarter last year, the firm earned $1.27 earnings per share. The firm’s revenue for the quarter was down 8.4% compared to the same quarter last year. As a group, research analysts anticipate that Agilent Technologies, Inc. will post 5.25 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be paid a dividend of $0.236 per share. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date is Tuesday, July 2nd. Agilent Technologies’s dividend payout ratio is presently 22.22%.

Wall Street Analyst Weigh In

A has been the subject of several recent analyst reports. Evercore ISI reduced their price target on Agilent Technologies from $145.00 to $126.00 and set an “in-line” rating for the company in a report on Thursday, May 30th. JPMorgan Chase & Co. reduced their price objective on Agilent Technologies from $165.00 to $155.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Jefferies Financial Group reaffirmed a “hold” rating and set a $135.00 price objective (down from $152.00) on shares of Agilent Technologies in a report on Monday, June 3rd. UBS Group reduced their price objective on Agilent Technologies from $155.00 to $141.00 and set a “neutral” rating for the company in a report on Thursday, May 30th. Finally, Stifel Nicolaus reduced their price objective on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a report on Thursday, May 30th. One analyst has rated the stock with a sell rating, six have given a hold rating and ten have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $136.50.

Get Our Latest Research Report on Agilent Technologies

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the transaction, the chief executive officer now owns 25,185 shares in the company, valued at $3,274,050. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the completion of the sale, the chief executive officer now directly owns 25,185 shares of the company’s stock, valued at $3,274,050. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Philip Binns sold 2,827 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $147.54, for a total value of $417,095.58. Following the completion of the sale, the senior vice president now directly owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The disclosure for this sale can be found here.

Agilent Technologies Profile

(Free Report)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

See Also

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.